173 related articles for article (PubMed ID: 12751702)
21. Predictors of corticosteroid-dependent and corticosteroid-refractory inflammatory bowel disease: analysis of a Chinese cohort study.
Chow DK; Sung JJ; Tsoi KK; Wong VW; Wu JC; Leong RW; Chan FK
Aliment Pharmacol Ther; 2009 Apr; 29(8):843-54. PubMed ID: 19154567
[TBL] [Abstract][Full Text] [Related]
22. Outcome of cytomegalovirus infections in patients with inflammatory bowel disease.
Papadakis KA; Tung JK; Binder SW; Kam LY; Abreu MT; Targan SR; Vasiliauskas EA
Am J Gastroenterol; 2001 Jul; 96(7):2137-42. PubMed ID: 11467645
[TBL] [Abstract][Full Text] [Related]
23. Symptom and disease severity differences between nasal septal deviation and chronic rhinosinusitis.
Bhattacharyya N
Otolaryngol Head Neck Surg; 2005 Aug; 133(2):173-7. PubMed ID: 16087008
[TBL] [Abstract][Full Text] [Related]
24. Prevalence of spondyloarthropathy in Puerto Rican patients with inflammatory bowel disease.
Rodriguez VE; Costas PJ; Vazquez M; Alvarez G; Perez-Kraft G; Climent C; Nazario CM
Ethn Dis; 2008; 18(2 Suppl 2):S2-225-9. PubMed ID: 18646354
[TBL] [Abstract][Full Text] [Related]
25. [Prevalence and characteristics of anemia in inflammatory bowel disease].
de la Morena López F; Gisbert JP
Gastroenterol Hepatol; 2009 Nov; 32(9):591-9. PubMed ID: 19631410
[TBL] [Abstract][Full Text] [Related]
26. Non-inflammatory joint pain in patients with inflammatory bowel disease is prevalent and has a significant impact on health related quality of life.
Palm Ø; Bernklev T; Moum B; Gran JT
J Rheumatol; 2005 Sep; 32(9):1755-9. PubMed ID: 16142874
[TBL] [Abstract][Full Text] [Related]
27. Does pregnancy change the disease course? A study in a European cohort of patients with inflammatory bowel disease.
Riis L; Vind I; Politi P; Wolters F; Vermeire S; Tsianos E; Freitas J; Mouzas I; Ruiz Ochoa V; O'Morain C; Odes S; Binder V; Moum B; Stockbrügger R; Langholz E; Munkholm P;
Am J Gastroenterol; 2006 Jul; 101(7):1539-45. PubMed ID: 16863558
[TBL] [Abstract][Full Text] [Related]
28. Increased rates of early adverse reaction to azathioprine in patients with Crohn's disease compared to autoimmune hepatitis: a tertiary referral center experience.
Bajaj JS; Saeian K; Varma RR; Franco J; Knox JF; Podoll J; Emmons J; Levy M; Binion DG
Am J Gastroenterol; 2005 May; 100(5):1121-5. PubMed ID: 15842588
[TBL] [Abstract][Full Text] [Related]
29. Mortality by medication use among patients with inflammatory bowel disease, 1996-2003.
Hutfless SM; Weng X; Liu L; Allison J; Herrinton LJ
Gastroenterology; 2007 Dec; 133(6):1779-86. PubMed ID: 18054550
[TBL] [Abstract][Full Text] [Related]
30. Prevalence and factors related to hepatitis B and C in inflammatory bowel disease patients in Spain: a nationwide, multicenter study.
Loras C; Saro C; Gonzalez-Huix F; Mínguez M; Merino O; Gisbert JP; Barrio J; Bernal A; Gutiérrez A; Piqueras M; Calvet X; Andreu M; Abad A; Ginard D; Bujanda L; Panés J; Torres M; Fernández-Bañares F; Viver JM; Esteve M;
Am J Gastroenterol; 2009 Jan; 104(1):57-63. PubMed ID: 19098850
[TBL] [Abstract][Full Text] [Related]
31. Predictors of medication adherence in inflammatory bowel disease.
Ediger JP; Walker JR; Graff L; Lix L; Clara I; Rawsthorne P; Rogala L; Miller N; McPhail C; Deering K; Bernstein CN
Am J Gastroenterol; 2007 Jul; 102(7):1417-26. PubMed ID: 17437505
[TBL] [Abstract][Full Text] [Related]
32. [Extra-intestinal manifestation of IBD in Veszprém county (of Hungary): results of a 25-years follow-up study].
Lakatos L; Pandur T; Dávid G; Balogh Z; Küronya P; Tollas A; Lakatos PL
Orv Hetil; 2003 Oct; 144(40):1965-75. PubMed ID: 14626638
[TBL] [Abstract][Full Text] [Related]
33. C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study.
Henriksen M; Jahnsen J; Lygren I; Stray N; Sauar J; Vatn MH; Moum B;
Gut; 2008 Nov; 57(11):1518-23. PubMed ID: 18566104
[TBL] [Abstract][Full Text] [Related]
34. Clinical presentation of inflammatory bowel disease: a hospital based retrospective study of 379 patients in eastern China.
Cao Q; Si JM; Gao M; Zhou G; Hu WL; Li JH
Chin Med J (Engl); 2005 May; 118(9):747-52. PubMed ID: 15899137
[TBL] [Abstract][Full Text] [Related]
35. The lung in inflammatory bowel disease.
Camus P; Piard F; Ashcroft T; Gal AA; Colby TV
Medicine (Baltimore); 1993 May; 72(3):151-83. PubMed ID: 8502168
[TBL] [Abstract][Full Text] [Related]
36. Therapy- and non-therapy-dependent infectious complications in inflammatory bowel disease.
Epple HJ
Dig Dis; 2009; 27(4):555-9. PubMed ID: 19897974
[TBL] [Abstract][Full Text] [Related]
37. Withdrawal of corticosteroids in inflammatory bowel disease patients after dependency periods ranging from 2 to 45 years: a proposed method.
Murphy SJ; Wang L; Anderson LA; Steinlauf A; Present DH; Mechanick JI
Aliment Pharmacol Ther; 2009 Nov; 30(10):1078-86. PubMed ID: 19735230
[TBL] [Abstract][Full Text] [Related]
38. Newer aspects of inflammatory bowel disease and its cutaneous manifestations: a selective review.
Apgar JT
Semin Dermatol; 1991 Sep; 10(3):138-47. PubMed ID: 1931561
[TBL] [Abstract][Full Text] [Related]
39. [Inflammatory bowel diseases as multi-focal disorders: results from a multi-regional survey on bodily and psychosocial problems in IBD patients].
Hardt J; Muche-Borowski C; Conrad S; Balzer K; Bokemeyer B; Raspe H
Z Gastroenterol; 2010 Mar; 48(3):381-91. PubMed ID: 20221992
[TBL] [Abstract][Full Text] [Related]
40. Management of inflammatory bowel disease during pregnancy and nursing.
Friedman S
Semin Gastrointest Dis; 2001 Oct; 12(4):245-52. PubMed ID: 11726078
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
